Quality
Specialist III Teva Pharmaceuticals B Pharm , M Pharm
Company
Info
Teva
is a global pharmaceutical leader and the world's largest generic medicines
producer, committed to improving health and increasing access to quality health
solutions worldwide. Our employees are at the core of our success, with
colleagues in over 80 countries delivering the world's largest medicine cabinet
to 200 million people every day.
We offer a uniquely diverse portfolio of
products and solutions for patients and we've built a promising pipeline
centered around our core therapeutic areas.
We are continually developing patient-centric solutions and significantly
growing both our generic and specialty medicines business through investment in
research and development, marketing, business development and innovation. This
is how we improve health and enable people to live better, healthier lives.
Join us on our journey of growth!
Job
Description
Role
:
The
job profile is completely into Quality Assurance (handling US product quality
complaints) , We only have reconciliation activity with pharmacovigilance team
.
We
dont deal with pharmacovigilence activities hugely .Its Purely qualityassurance
role.
Handling
of specific responsibilities assigned by QAS Management
Participate
and contribute to the continous improvement activities of the QAS GroupT
Expectation
from candidate :
Looking
for a candidate with 2-4 years of experience post B Pharma completion. Should
have sound knwoleage about pharmaceutical dosage forms,its indication and
common product quality complaints that can occur.
Good
knowledge of product quality complaints management and handling QA activities
(preferred not mandatory)
Experience
in handling different types of application related to product complaints
management like track wise.
Should
be excellent in english communication since this would be working with US peers
and also would be for night shift.
candidate
should be from Mumbai preferable from Western Line . Only Male candidates .
TO APPLY CLICK HERE
FOR MORE JOB UPDATES
No comments:
Post a Comment